Measurement of Human and Mouse Interleukin 18

Tomohiro Yoshimoto1, Hiroko Tsutsui1, Haruki Okamura1, Kenji Nakanishi1

1 Hyogo College of Medicine, Hyogo, Japan
Publication Name:  Current Protocols in Immunology
Unit Number:  Unit 6.26
DOI:  10.1002/0471142735.im0626s44
Online Posting Date:  November, 2001
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

IL‐18, originally designated as interferon‐γ (IFN‐γ)‐inducing factor (IGIF), is a pleiotropic cytokine secreted by activated macrophages and Kupffer cells. The major activity associated with this cytokine is induction of IFN‐γ production from T cells, B cells, and NK cells, especially in collaboration with IL‐12. IL‐18 is synthesized without a signal peptide and must be enzymatically cleaved to become active. Therefore, it is important to determine whether the produced IL‐18 is an active or precursor form. This unit describes functional assays for measurement of bioactive human and mouse IL‐18 and ELISAs for measurement of murine and human IL‐18 proteins. The functional assays are based on the induction of IFN‐γ production by IL‐18. The ELISA measures the concentration of human or mouse IL‐18. Using a combination of monoclonal antibodies against human or mouse IL‐18, the proform and/or mature form of IL‐18 can be detected by ELISA.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Basic Protocol 1: IFN‐γ Induction Assay to Quantitate Mouse and Human IL‐18
  • Basic Protocol 2: ELISA for Human and Mouse IL‐18
  • Reagents and Solutions
  • Commentary
  • Figures
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: IFN‐γ Induction Assay to Quantitate Mouse and Human IL‐18

  Materials
  • Mice (BALB/c or C57BL/6 strain)
  • Anti‐asialo GM1 antibody (Wako)
  • Mouse IL‐12 (e.g., R & D Systems)
  • Mouse IL‐18 reference standard (commercially available from MBL International)
  • recipeComplete RPMI‐10 medium (see recipe)
  • Unknown sample for assay of IL‐18
  • Mouse or human IFN‐γ ELISA kits (e.g., R & D Systems)
  • 17 × 100‐mm polystyrene tubes
  • 96‐well flat‐bottom microtiter plates with lids (e.g. Costar)
  • 24‐well plates (e.g., Falcon)
  • Multichannel and repeating pipettors
  • Additional reagents and supplies for intravenous injection of mice (unit 1.6) and preparing mouse splenic T cells (unit 3.2)
NOTE: All solutions and equipment coming into contact with cells must be sterile, and aseptic technique should be used accordingly.NOTE: All culture incubations are performed in a humidified 37°C, 5% CO 2 incubator unless otherwise indicated.

Basic Protocol 2: ELISA for Human and Mouse IL‐18

  Materials
  • recipeELISA coating antibody (see recipe) appropriate for human or mouse IL‐18
  • Coating buffer: PBS ( appendix 2A), pH 7.4
  • Washing buffer: Dulbecco's phosphate‐buffered serum (D‐PBS; e.g., Life Technologies) containing 0.01% (v/v) Tween 20; store up to 1 week at room temperature
  • Blocking solution: Dulbecco's phosphate‐buffered serum (D‐PBS; e.g., Life Technologies) containing 1% (w/v) bovine serum albumin (BSA); store up to 4 weeks at 4°C
  • IL‐18 reference standard (commercially available from MBL International)
  • Unknown sample containing IL‐18
  • recipeAssay buffer (see recipe)
  • recipeConjugation buffer (see recipe)
  • Peroxidase conjugated rat anti‐human IL‐18 monoclonal antibody (159‐12B) or anti‐mouse IL‐18 monoclonal antibody (93‐10C): available from MBL International
  • Chromogenic substrate for detecting peroxidase: e.g., tetramethylbenzidine (TMB)/H 2O 2 (Becton Dickinson), prepared according to manufacturer's instructions
  • Stop solution appropriate for substrate employed (e.g., 2 N H 2SO 4)
  • Multichannel and repeating pipettors
  • 96‐well EIA plates with plate sealers (e.g., EIA/RIA plate from Costar)
  • ELISA plate reader (e.g., Benchmark, Bio‐Rad) with appropriate filter for peroxidase substrate employed
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
   Akira, S. 2000. The role of IL‐18 in innate immunity. Curr. Opin. Immunol. 12:59‐63.
   Dinarello, C.A., 1999. IL‐18: A TH1‐inducing, proinflammatory cytokine and new member of the IL‐1 family. J. Allergy Clin. Immunol. 103:11‐24.
   Dao, T., Ohashi, K., Kayano, T., Kurimoto, M., and Okamura, H., 1996. Interferon‐γ‐inducing factor, a novel cytokine, enhances Fas ligand‐ mediated cytotoxicity of murine T helper 1 cells. Cell Immunol. 173:230‐235.
   Fantuzzi, G. and Dinarello, C.A. 1999. Interleukin‐18 and interleukin‐1β: Two cytokine substrates for ICE (caspase‐1) J. Clin. Immunology 19:1‐11.
   Fujimori, Y., Takatsuka, H., Takemoto, Y., Hara, H., Okamura, H., Nakanishi, K., and Kakishita, E. 2000. Elevated interleukin (IL)‐18 levels during acute graft‐versus‐host disease after allogenic bone marrow transplantation. Br. J. Haematol. 109:652‐657.
   Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M.A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., Kurimoto, M., Tanimoto, T., Flavell, R.A., Sato, V., Harding, M.W., Livingston, D.J., and Su, M.S. 1997. Activation of interferon‐γ inducing factor mediated by interleukin‐1β converting enzyme. Science 275:206‐209.
   Hoshino, T., Wiltrout, R.H., and Young, H.A. 1999. IL‐18 is a potent coinducer of IL‐13 in NK and T cells: A new potential role for IL‐18 in modulating the immune response. J. Immunol. 30:1998‐2006.
   Hoshino, T., Yagita, H., Ortaldo, J.R., Wiltrout, R.H., and Young, H.A. 2000. In vivo administration of IL‐18 can induce IgE production through Th2 cytokine induction and up‐regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur. J. Immunol. 162:5070‐5077.
   Hyodo, Y., Matsui, K., Hayashi, N., Tsutsui, H., Kashiwamura, S., Yamauchi, H., Hiroishi, K., Takeda, K., Tagawa, Y., Iwakura, Y., Kayagaki, N., Kurimotor, M., Okamura, H., Hada, T., Yagita, H., Akira, S., Nakanishi, K., and Higashino, K. 1999. IL‐18 up‐regulates perforin‐mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL‐18 receptor. J. Immunol. 162:1662‐1668.
   Kikkawa, S., Shida, K., Okamura, H., Begum, N.A., Matsumoto, M., Tsuji, S., Nomura, M., Suzuki, Y., Toyoshima, K., and Seya, T. 2000. A comparative analysis of the antigenic, structural, and functional properties of three different preparations of recombinant human interleukin‐18. J. Interferon Cytokine Res. 20:179‐85.
   Konishi, K., Tanabe, F., Taniguchi, M., Yamauchi, H., Tanimoto, T., Ikeda, M., Orita, K., and Kurimoto, M. 1997. A simple and sensitive bioassay for the detection of human interleukin‐18/interferon‐γ‐inducing factor using human myelomonocytic KG‐1 cells. J. Immunol. Methods 209:187‐191.
   Kohno, K., Kataoka, J., Ohtsuki, T., Suremoto, Y., Okamoto, I., Usui, M., Ikeda, M., and Kurimoto, M. 1997. IFN‐γ‐inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL‐12. J. Immunol. 158:1541‐1550.
   Nakamura, H., Komatsu, K., Ayaki, M., Kawamoto, S., Murakami, M., Uoshima, N., Yagi, T., Hasegawa, T., Yasumi, M., Karasumoto, T., Teshima, H., Hiraoka, A., and Masaoka, T. 2000. Serum levels of soluble IL‐2 receptor, and IL‐12, IL‐18, and IFN‐γ in patients with acute graft‐versus‐host disease after allogenic bone marrow transplantation. J. Allergy Clin. Immunol. 106:45‐50.
   Nakanishi, K., Yoshimoto, T., Tsutsui, H., and Okamura, H. 2001a. Interleukin‐18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 12:53‐72.
   Nakanishi, ,K., Yoshimoto, T., Tsutsui, H., and Okamura, H. 2001b. Interleukin‐18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:423‐74.
   Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Akita, K., Namba, M., Tanabe, F., Konishi, K., Fukuda, S., and Kurimoto, M. 1995. Cloning of a new cytokine that induces IFN‐γ production by T cells. Nature 378:88‐91.
   Okamura, H., Tsutsui, H., Yoshimoto, T., and Nakanishi, K. 1998. Interleukin‐18: A novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70:281‐312.
   Okamura, H., Kashiwamura, S.‐I., Tsutsui, H., Yoshimoto, T., and Nakanishi, K. 1998. Regulation of interferon‐gamma (IFN‐γ) production by IL‐12 and IL‐18. Curr. Opin. Immunol. 10:259‐264.
   O'Neill, L.A. and Dinarello, C.A. 2000. The IL‐1 receptor/toll‐like receptor superfamily: Crucial receptors for inflammation and host defense. Immunol. Today 21:206‐209.
   Puren, A.J., Fantuzzi, G., and Dinarello, C.A. 1999. Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1β are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc. Natl. Acad. Sci. U.S.A. 96:2256‐2261.
   Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S.B., Menon, S., Kastelein, R., Bazan, F., and O'Garra, A. 1997. IGIF does not drive Th1 development but synergizes with IL‐12 for interferon‐γ production and activates IRAK and NF‐κB. Immunity 7:571‐581.
   Stoll, S., Muller, G., Kurimoto, M., Saloga, J., Tanimoto, T., Yamauchi, H., Okamura, H., Knop, J., and Enk, A. H. 1997. Production of IL‐18 (IFN‐γ‐inducing factor) messenger RNA and functional protein by murine keratinocytes. J. Immunol. 159:298‐302.
   Stoll, S., Jonuleit, H., Schmitt, E., Muller, G., Yamauchi, H., Kurimoto, M., Knop, J., and Enk, A.H. 1998. Production of functional IL‐18 by different subtypes of murine and human dendritic cells (DC): DC‐derived IL‐18 enhances IL‐12‐dependent Th1 development. Eur. J. Immunol. 28:3239‐63.
   Taniguchi, M., Nagaoka, K., Kunikata, T., Kayano, T., Yamauchi, H., Nakamura, S., Ikeda, M., Orita, K., and Kurimoto, M. 1997. Characterization of anti‐human interleukin‐18 (IL‐18)/interferon‐γ‐inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL‐18 by ELISA. J. Immunol. Methods. 206:107‐113.
   Taniguchi, M., Nagaoka, K., Ushio, S., Nukada, Y., Okura, T., Mori, T., Yamauchi, H., Ohta, T., Ikegami, H., and Kurimoto, M. 1998. Establishment of the cells useful for murine interleukin‐18 bioassay by introducing murine interleukin‐18 receptor cDNA into human myelomonocytic KG‐1 cells. J. Immunol. Methods. 217:97‐102.
   Tominaga, K., Yoshimoto, T., Torigoe, K., Kurimoto, M., Matsui, K., Hada, T., Okamura, H., and Nakanishi, K. 2000. IL‐12 synergizes with IL‐18 or IL‐1β for IFN‐γ production from human T cells. Int. Immunol. 12:151‐160.
   Tsutsui, H., Nakanishi, K., Matsui, K., Higashino, K., Okamura, H., Miyazawa, Y., and Kaneda, K. 1996. Interferon‐γ‐inducing factor up‐regulates Fas ligand‐mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157:3967‐3973.
   Tsutsui, H., Matsui, K., Kawada, N., Hyodo, Y., Hayashi, N., Okamura, H., Higashino, K., and Nakanishi, K. 1997. IL‐18 accounts for both TNF‐α‐ and Fas ligand‐mediated hepatotoxic pathways in endotoxin‐induced liver injury in mice. J. Immunol. 159:3961‐3967.
   Tsutsui, H., Kayagaki, N., Kuida, K., Nakano, H., Hayashi, N., Takeda, K., Matsui, K., Kashiwamura, S., Hada, T., Akira, S., Yagita, H., Okamura, H., and Nakanishi, K. 1999. Caspase‐1‐independent, Fas/Fas ligand‐mediated IL‐18 secretion from macrophages causes acute liver injury in mice. Immunity 11:259‐367.
   Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Akita, K., Tanabe, F., Konishi, K., Micallef, M., Fujii, M., Torigoe, K., Tanimoto, T., Fukuda, S., Ikeda, M., Okamura, H., and Kurimoto, M. 1996. Cloning of the cDNA for human IFN‐γ‐inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156:4274‐4279.
   Yoshimoto, T., Okamura, H., Tagawa, Y.‐I., Iwakura, Y., and Nakanishi, K. 1997. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon‐γ production from activated B cells. Proc. Natl. Acad. Sci. U.S.A. 94:3948‐3953.
   Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Okamura, H., Akira, S., and Nakanishi, K. 1998. IL‐12 up‐regulates IL‐18 receptor expression on T cells Th1 cells, and B cells: synergism with IL‐18 for IFN‐γ production. J. Immunol. 161:3400‐3407.
   Yoshimoto, T., Tsutsui, H., Tominaga, K., Hoshino, K., Okamura, H., Akira, S., Paul, W.E., and Nakanishi, K. 1999. IL‐18, although anti‐allergic when administered with IL‐12, stimulates IL‐4 and histamine release by basophils. Proc. Natl. Acad. Sci. U.S.A. 96:13962‐13966.
   Yoshimoto, T., Mizutani, H., Tsutsui, H., Noben‐Trauth, N., Yamanaka, K‐I., Tanaka, M., Izumi, S., Okamura, H., Paul, W.E., and Nakanishi, K. 2000. IL‐18 induction of IgE: Dependence on CD4+ T cells, IL‐4 and Stat6. Nature Immunol 1:132‐137.
Key Reference
   Okamura, H. et al. 1995. See above.
  An original paper of IL‐18.
   Nakanishi, K. et al., 2001b. See above.
  Excellent reviews of all facts of IL‐18 biology, biochemistry, and molecular biology.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library